However, SCD1 inhibition has also been suggested to be a new therapeutic target for preventing type 2 diabetes itself, because SCD1 knockout mice showed resistance to HFD-induced obesity and insulin resistance [35]. The gene discussed is SCD; the disease is obesity disorder.